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Abstract: Halloysite is an aluminosilicate clay that has been widely used for controlled drug 
delivery, immobilization of enzymes, and for the capture of circulating tumor cells (CTCs). 
Surface modification of halloysite by organosilanes has been explored to improve their 
properties. In this study halloysite clay nanotubes (HNTs) were functionalized by two 
different organosilanes: Trimethoxy(propyl)silane (TMPS), and Triethoxy(octyl)silane 
(EOS). Untreated and modified samples were characterized by scanning electron microscopy 
(SEM), X-ray diffractometry (XRD), thermogravimetrical analysis (TGA), and Fourier 
transform infrared spectroscopy (FTIR). Results showed a strong interaction of organosilanes 
with the chemical groups present in HNTs. Biocompatibility and cytotoxicity of these 
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nanomaterials were determined using C6 rat glioblastoma cells. Our results indicate that prior 
to functionalization, HNTs show a high biocompatibility and low cytotoxicity. However, 
HNTs functionalized with EOS and TMPS showed high cytotoxicity by inducing apoptosis. 
These results allow the identification of potential applications in biomedical areas for HNTs. 
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1. Introduction 
Halloysite nanotubes (HNTs) have been recently used due to their unique properties such as their hollow 
tubular structure, high surface area, surface characteristics, and high biocompatibility [1–6]. HNT tubules 
consist of a two layered aluminosilicate clay (Al2Si2O5(OH)4·2H2O) with an external diameter of 50–80 nm, 
lumen diameter of 10–15 nm, and length of 1000 nm [7]. The tubes have multilayer walls with positively 
charged Al–OH functional groups on the inner surface, and with negatively charged Si–OH functional 
groups on the outer surface [8]. These characteristics make HNTs a great absorbent for both cationic and 
anionic molecules [1–5]. Furthermore, their nanosized lumen enables entrapping a range of active agents 
such as macromolecules, and proteins [9]. The advantages of these nanoparticles compared to carbon 
nanotubes, which have been extensively studied for a wide range of applications, are that HNTs are not 
toxic for the human body nor hazardous for the environment, and have lower manufacturing costs [7]. 
For these reasons HNTs have been studied for diverse biomedical applications, including inexpensive 
drug encapsulation [8,10–12], as a template or nanoreactor for biocatalyst [13], as well as for use in 
personal care and cosmetics [14]. Zhai et al. [15] demonstrated that HNTs can also be used to immobilize 
enzymes, such as the α-amylase and urease with the objective of extending their catalytic lifetime. This 
study showed that the immobilized enzymes had more than 90% of activity due to the presence of HNTs 
after 15 days. Moreover, HNTs have shown to be successful for enhanced isolation and capture of 
circulating tumor cells (CTCs) in blood [16–18]. For example, Hughes et al. [17] designed a microscale 
flow device for isolating CTCs where the addition of a HNT coating improved capture purities. Targeted 
drug delivery to CTCs has also being achieved with HNT-liposome coated surfaces [19,20], thus 
reducing the probability of metastasis and chemotherapeutic dosages, as shown by Mitchell et al. [20]. 
HNTs may be modified either with salts or organosilanes [21] in order to improve the interaction with 
polymer matrices [22–24]. It has been proved that coating HNTs with organic molecules on its surface 
may reduce agglomeration due to its interaction with organic media. According to Gironès et al. [25], 
organosilanes are widely used because of their low cost and availability. Yuan et al. [8] modified HNTs 
with γ-Aminopropyltriethoxysilane (APTES) by direct grafting of the organosilane onto the surface 
hydroxyl groups. Similarly, Shi et al. [26] functionalized HNTs with APTES to use them as carriers of 
therapeutic gene antisense oligodeoxynucleotides (ASODNS). Due to the large aspect ratio, good 
biocompatibility, and high mechanical strength of the modified HNTs, it was demonstrated that these 
nanotubes are a promising vector for gene therapy applications. 
In this study HNTs were functionalized with two different organosilanes: Trimethoxy(propyl)silane 
(TMPS), and Triethoxy(octyl)silane (EOS), and characterized by scanning electron microscopy (SEM), 
X-ray diffractometry (XRD), thermogravimetrical analysis (TGA), and Fourier transform infrared 
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spectroscopy (FTIR). The biocompatibility and cytotoxicity of these materials was determined using C6 
rat glioblastoma cell cultures. SEM, FTIR, TGA, and cytotoxicity results from the untreated and modified 
HNTs were previously presented at the First International Electronic Conference on Materials [27]. 
2. Experimental Method 
2.1. Materials 
HNTs, Trimethoxy(propyl)silane (TMPS), and Triethoxy(octyl)silane (EOS) were purchased from  
Sigma-Aldrich (St. Louis, MO, USA). Analytical grade acetone from CTR (Monterrey, Mexico) was also used 
for sample preparation. Collagen from calf skin, acetic acid, and Phosphate buffered saline (PBS) were obtained 
from Sigma-Aldrich. Dulbecco’s Modified Eagle’s medium (DMEM) medium, fetal bovine serum (FBS),  
L-glutamine, trypsin, and penicillin-streptomycin are from Life Technologies (New York, NY, USA). 
2.2. Functionalization of HNTs 
HNTs were functionalized with two different organosilanes, namely Trimethoxy(propyl)silane, and 
Triethoxy(octyl)silane. Functionalization was carried out by mixing in a flask ball 10 g of HNTs, 50 mL 
of acetone, and 2 mL of organosilane material. The samples were heated at 50 °C for 48 h in order to 
eliminate unreacted materials. Finally, the suspensions were vacuum filtered to obtain a solid phase. 
2.3. Characterization Methods 
FTIR-ATR spectra were obtained with a Perkin Elmer SPECTRUM 400 spectrometer (Waltham, 
MA, USA) using a ZnSe trapezoidal shaped ATR element. Sample spectrum and background were 
acquired with the coated ATR element and the clean ATR element, respectively. The spectra were 
acquired with a resolution of 4 cm−1 and 16 scans. An FEI Nova NanoSEM 200 scanning electron 
microscope (SEM) (Hillsboro, OR, USA), with an acceleration voltage of 15 kV, and secondary electron 
detector under vacuum, was used to characterize the morphology of the untreated and functionalized 
HNTs. The Energy-dispersive X-ray spectroscopy (EDS) elemental analysis was performed using an 
INCA X-Sight (Abingdon, UK). XRD analysis was performed by an Empyrean PANalytical 
diffractometer (Boulder, CO, USA) with an X’Cellerator detector in a continuous mode scanning with a 
start angle of 30.000°, and end angle of 100.000°, a step size of 0.02, and time per step of 1 s.  
An X-ray tube copper wavelength (λ) of 1.5405 was used, at a voltage of 45 kV, and current of 40 mA. 
Decomposition temperatures of samples were determined by thermogravimetrical analysis (TGA) with 
a TA Instruments SDT Q600 (New Castle, DE, USA). All samples were heated al 10 °C/min from room 
temperature (25 °C) to 850 °C under 100 mL/min nitrogen purge. 
2.4. Cell Culture 
C6 Rat glioblastoma cells were obtained from American Type Culture Collection (cat. no. CCL-107, 
Manassas, VA, USA). The cell line was cultured at 37 °C under recommended conditions in tissue  
culture-treated plastic dishes (Corning) with DMEM medium supplemented with 10% FBS,  
2 mM L-glutamine, 100 U/mL of penicillin, and 100 μg/mL streptomycin. 
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2.5. Cytotoxicity Analysis 
Materials were autoclaved for 15 min at 100 °C, followed by a 30 min drying cycle. Then, they were 
left to cool, and stored at room temperature (25 °C). 
Cell culture-treated 96-well fluorescence microplates (Corning, cat. no 3916, Corning, NY, USA) 
were covered with a 0.05 mg/mL solution of collagen in 0.1 M of acetic acid overnight. After this 
incubation step, the wells were washed 3 times with phosphate buffered saline solution (PBS, 0.1 M 
phosphate buffer, 0.9% w/v sodium chloride, pH 7.2). After washing, 20,000 C6 cells were plated per 
well, and incubated overnight to reach 60% confluence. At this moment, the different treatments (see 
Table 1) were administered, and cells were incubated overnight. Cytotoxicity and apoptosis assays where 
then performed using the ApoTox-Glo Triplex assay (Promega, cat. no. G6320, Fitchburg, WI, USA) 
following the manufacturer’s recommendations. 
Assays were read in a GloMax automated plate fluorometer (Promega) at 402 nm/505 nm 
(excitation/emission) for cell viability, and at 485 nm/520 nm for cytotoxicity assessments. 
Table 1. Experimental groups used to evaluate cytotoxicity of halloysite clay nanotubes 
(HNTs) derivatives. 
Reaction Cells Collagen HNTs HNTs–TMPS HNTS–EOS
Control X – – – – 
Collagen X X – – – 
HNTs/Collagen X X 0.05% – – 
HNTs–TMPS/Collagen X X – 0.05% – 
HNTs–EOS/Collagen X X – – 0.05% 
X: indicate the presence of a component; –: indicate absence. 
A control group was included to evaluate base-line cell mortality at 80% confluence. Collagen was 
included in all the groups exposed to nanomaterial derivatives. Nanomaterials were first re-suspended 
as colloidal suspensions at 5% (w/v) in cell culture medium, and then stirred prior to diluting to final 
concentrations of 500 µg/mL in fresh medium before adding the mixture to the cell cultures. 
The results obtained from cytotoxicity tests were analyzed using Sigma Stat 3.5 program (SYSTAT, 
San Jose, CA, USA). Data were statistically analyzed with a one-way ANOVA test, and Bonferroni 
multiple comparisons post-hoc test. 
3. Results and Discussion 
3.1. Characterization Results 
Figure 1 depicts the FTIR spectrums of HNTs, HNTs–TMPS, and HNTs–EOS. The vibrational mode 
at 2924 cm−1 on Figure 1b and Figure 1c corresponds to the methyl and methylene groups (area marked 
with a circle), that are not present in HNTs, confirming the chemical interaction with Al–O or Si–O 
functional groups of HNTs. The HNTs–TMPS and HNTs–EOS show some signals due to HNTs, such as 
the deformations of Al–O–Si and Si–O–Si at 536 and 462 cm−1, respectively, the O–H groups of the 
inner hydroxyl groups at 909 cm−1. Compared to HNTs no other characteristic signals are detected in 
HNTs–TMPS or in HNTs–EOS. 
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Figure 1. FTIR images of (a) HNTs; (b) HNTs–Trimethoxy(propyl)silane (TMPS);  
(c) HNTs–Triethoxy(octyl)silane (EOS). 
 
SEM images of HNTs, with a diameter of 20–135 nm and various lengths, are shown in Figure 2. 
Micrographs show that HNTs (Figure 2a), HNTs–TMPS (Figure 2b) and HNTs–EOS (Figure 2c) have 
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no significant structural changes, showing only particles formed in fibers or wires with nanometric sizes. 
This is confirmed by XRD diffractograms, as shown in Figure 3. 
Figure 2. SEM images of (a) HNTs; (b) HNTs–TMPS; (c) HNTs–EOS. 
 
Table 2 depicts the EDS analysis results in wt%. This test proved that the major constituents for the 
HNTs, HNTs–TMPS, and HNTs–EOS were Al, Si, and O. The carbon content is not included because 
the sample particles were supported on a carbon ribbon.  
Table 2. Energy-dispersive X-ray spectroscopy (EDS) analysis results. 
Material O (wt%) Al (wt%) Si (wt%)
HNTs 61.84 18.48 19.69 
HNTs–TMPS 60.85 19.22 19.94 
HNTs–EOS 62.57 19.92 17.51 
Figure 3 presents the diffractograms obtained by XRD of the three samples (HNTs, HNTs–TMPS, 
and HNTs–EOS), showing no significant differences between them. In the three solids the following 
phases were identified: Halloysite-7A, and Halloysite-14A. Furthermore, the phases of SiO2 and 
Al(OH)3 were indexed. The three solids are composed basically of two polymorphs of the bilaminar clay 
(1:1) dioctahedral Halloysite, in the presence of SiO2 and Al(OH)3. Thus, it is concluded that during the 
process of functionalization, a modification of the chemical structure of Halloysite is not appreciated. 
Table 3 shows the weight loss (%) at 200–320 °C for functionalized and untreated HNTs obtained by 
TGA. The higher weight loss shown from HNTs–EOS compared to HNTs–TMPS is consistent with the 
higher hydrocarbon chain of the octyl group from EOS. This also supports the strong chemical 
interaction of the organosilanes with the Si–O and Al–O groups of HNTs. The remaining materials at 
800 °C (~81%) are oxides of aluminum and silicon, compounds present in HNTs. 
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Figure 3. Diffractograms of (a) HNTs; (b) HNTs–TMPS; (c) HNTs–EOS. 
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Table 3. Weight loss by thermogravimetrical analysis (TGA) of HNTs and functionalized HNTs. 
Sample Weight Loss in TGA,  200–320 °C (%) 
Difference Relative to 
HNTs (%) 
HNTs 1.86 – 
HNTs–TMPS 1.94 0.08 
HNTs–EOS 2.04 0.18 
3.2. Cytotoxicity Results 
Figure 4 shows the cytotoxic and apoptotic effects of unmodified and organosilane functionalized HNTs. 
Figure 4. Cytotoxic and apoptotic effects of HNTs derivatives. Organosilane derivatives of 
HNTs (TMPS, EOS) increase cell mortality after 24 h exposure (a) These cytotoxic effect is 
mediated by a pro-apoptotic activity; (b) Unmodified HNTs do not show a statistically 
significant increase in cytotoxicity although they do increase apoptosis, albeit at a lower level. 
* denotes p < 0.01. 
 
Unmodified HNTs do not appear to have cytotoxic effects after a 24 h exposure period in C6 glioma 
cell cultures. However, TMPS- and EOS-functionalized HNTs increased cell mortality after incubating 
under the same conditions (Figure 4a). These cytotoxic effects are due to an increase in apoptosis,  
which is also observed in cultures exposed to unmodified HNTs (Figure 4b). It is possible that HNTs 
activate pro-apoptotic signaling in C6 cells, which can be enhanced by organosilane functionalization, 
leading to increased cell death after 24 h only by exposure to these derivatives.  
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This cytotoxic effect could take longer exposure times to be appreciated with unmodified HNTs and it 
is necessary to perform further experiments to determine if this is the case. Moreover, evaluation on other 
cell types is necessary in order to determine whether induction of apoptosis is cell-type specific or not. 
Previous studies by Vergaro et al. [6] showed that both non-functionalized HNTs and  
APTES-functionalized HNTs appear to be well tolerated by breast cancer cell (MCF-7) cultures on 
concentrations up to 75 μg/mL, with a decrease in cell vitality at higher concentrations. Our results show 
that at 500 μg/mL organosilane functionalization of HNTs increase pro-apoptotic activity that leads to 
enhanced cytotoxic effects, however non-functionalized HNTs at the same concentration appear to be 
biocompatible. Differences in the cytotoxicity observed in our study could be due to the effect of the 
chemical nature of the organosilane derivatives we used, or on the other hand, from the different 
approaches used to determine cytotoxicity: Vergaro et al. [6] used the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction assay, which is dependent on cell metabolism. Reduction 
of MTT can be altered by a number of factors that do not lead to apoptosis, including, but not limited to, 
disruptors of mitochondrial function and inhibitors of cell proliferation with no cytotoxic effects [28], 
while our assays determine the release of cytosolic proteases and the level of activation of the caspase 
pathway [29]. It would be interesting to evaluate if further functionalization with large biomolecules or 
therapeutic drugs could revert the cytotoxic activity of the organosilane derivatives. 
4. Conclusions  
Functionalization of HNTs was achieved by modification with TMPS and EOS organosilanes. 
Characterization by FTIR and TGA showed the strong interaction of organosilanes with the chemical 
groups present in HNTs. This functionalization may be useful to improve the properties of HNTs for 
several applications, including drug encapsulation and delivery, biocatalysis, and for nanocomposites 
with enhanced mechanical properties. Cytotoxicity of untreated and functionalized HNTs was characterized. 
Results showed that at the selected concentration HNTs showed to be a highly biocompatible material, 
however, functionalization by selected organosilanes exhibited high cytotoxicity, inducing cell death  
by apoptosis. 
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